CHICAGO -- Chromatin, Inc., today announced that it has completed a Series C financing round of $12.4 million, led by Quantitative Financial Strategies, Inc. ("Quant") (Greenwich, CT), and joined by the Malaysian Life Sciences Capital Fund ("MLSCF") and Chromatin's existing investors Burrill & Company, Venture Investors, Unilever Technology Ventures, Foragen Technology Ventures, and Illinois Ventures.
MORE